The fat and thin of lipin  by Reitman, Marc L.
PreviewsThe fat and thin of lipin
Mutations in the Lpin1 gene (encoding lipin) cause the lipodystrophy (adipose tissue deficiency) of the fld mouse, but the
underlying mechanism has been unclear. In this issue of Cell Metabolism, Phan and Reue (2005) show that overexpression
of lipin in either muscle or adipose tissue increases adiposity. Interestingly, mice overexpressing lipin in muscle are insulin
resistant, while those overexpressing lipin in adipose tissue are insulin sensitive.Much of the human race is obsessed o
with physical appearance and body o
weight. At the same time, scientists love t
mysteries. Lipodystrophy, a condition in u
which the lack of fat paradoxically
causes the medical complications nor- d
mally found in obesity, therefore poses p
a particularly intriguing puzzle. The fatty t
liver dystrophy (fld, officially Lpin1fld/fld) c
mouse is lipodystrophic, with transient 2
fatty liver and peripheral neuropathy, l
due to a mutation in the lipin gene (Pe- m
terfy et al., 2001). However, the func- t
tions of lipin and the tissues relevant to c
the complete mutant phenotype are not p
known. In this issue of Cell Metabolism, O
Phan and Reue address lipin function by a
producing transgenic mice overexpress- a
ing lipin selectively in either adipose tis- c
sue or muscle (Phan and Reue, 2005). t
The lipodystrophies constitute a hetero- p
geneous group of syndromes charac- d
terized by adipose deficiency. The cause a
can be genetic (with at least five human c
monogenic causes: LMNA, BSCL2,
PPARG, AGPAT2, and ZMPSTE24), au- i
toimmune/inflammatory, or associated h
with effectively treated HIV infection s
(Garg, 2004). The major metabolic se- m
quelae of lipodystrophy are insulin resis- T
tance, hepatic steatosis, and hypertri- c
glyceridemia, each of which can be d
extreme. These same conditions are l
common sequelae of obesity. c
The fld mouse is lipodystrophic (re- o
duced adipose tissue mass, transiently t
fatty liver, insulin resistance, increased b
blood triacylglycerol levels, and athero- w
sclerosis) with peripheral neuropathy. s
The phenotype is caused by mutations m
in a previously uncharacterized gene, h
Lpin1, encoding lipin, a large (900 amino e
acid), conserved, intracellular (usually f
nuclear) protein expressed in many tis- i
sues (Peterfy et al., 2001). Later work t
showed lipin to be important for adipose c
differentiation (Phan et al., 2004). While a
there are numerous illuminating exam- p
ples in genetics in which identification of s
the causative mutations furnishes anCELL METABOLISM : JANUARY 2005 · VOL. 1 ·bvious mechanistic explanation for the a
bserved phenotype, this is not so for w
he fld mouse, leaving many questions d
nanswered. m
The primary cause of the metabolic w
erangements of lipodystrophy is adi- t
ose tissue deficiency, since adipose b
issue transplantation can reverse the d
omplete syndrome (Gavrilova et al., i
000). Leptin deficiency caused by the u
ack of fat is a major contributor (Shimo- p
ura et al., 1999). How does a null mu- i
ation in Lpin1, a widely expressed gene, p
ause a phenotype that can be ex- c
lained by a defect in a single tissue? a
ne way to answer this question is to a
blate lipin in a tissue-specific manner 1
nd determine which single-tissue defi- p
iency reproduces specific aspects of 2
he phenotype. While we await such ex- o
eriments, Phan and Reue (2005) have o
one a complementary experiment, cre- i
ting transgenic mice with tissue-spe- a
ific lipin overexpression. T
Muscle lipin overexpression causes s
ncreased adiposity on either a chow or
g
igh-fat diet, accompanied by insulin re-
istance. These mice have a decreased
netabolic rate and body temperature.
she respiratory quotient (RQ) and mus-
hle RNA profiles are consistent with re-
iuced fatty acid oxidation and increased
oipid storage. However, muscle lipin defi-
niency does not explain the phenotype
of the fld mouse, because breeding the
lransgene onto the homozygous fld
Gackground did not rescue the body
leight/adiposity phenotype. The data
phow that overexpression of lipin in
euscle has a profound effect on energy
lomeostasis. A likely scenario is that the
oxtra muscle lipin decreases muscle
datty acid oxidation, with obesity result-
2ng from the decreased energy expendi-
iure. The insulin resistance may be se-
qondary to the obesity or to a direct
wction of lipin in muscle; the current ex-
periments do not distinguish these pos-
libilities.
Adipose lipin overexpression caused aCOPYRIGHT © 2005 ELSEVIER INC.more modest increase in adiposity,
hich was detected only on the high-fat
iet. Feed efficiency and adipose tissue
RNA levels of a few lipogenic genes
ere increased. No difference was de-
ected in food intake, metabolic rate,
ody temperature, or RQ. Interestingly,
espite the obesity, these mice showed
ncreased insulin sensitivity. We do not
nderstand the molecular basis for this
aradox. Other models of obesity with
ncreased insulin sensitivity include adi-
ose-selective overexpression of a glu-
ose transporter (Shepherd et al., 1993);
blation of aP2, an adipose tissue fatty
cid binding protein (Hotamisligil et al.,
996); and adipose-selective overex-
ression of PEPCK (Franckhauser et al.,
002). A possible explanation for the
verexpression phenotype is that lipin
verexpression increases insulin signal-
ng in adipose tissue, reducing lipolysis
nd increasing adipose glucose uptake.
hese increase whole-body insulin sen-
itivity by reducing nonadipose triacyl-
lycerol stores (reducing “lipotoxicity”).
The molecular functions of lipin are
ot well understood. Lipin contains con-
erved N- and C-terminal domains, and
omologs with these motifs and organ-
zation have been identified in all eukary-
tes examined. An S. pombe homolog,
ed1, contributes to nuclear morphol-
gy and chromosome stability, and it is
ikely that Ned1 interacts with the Ran-
TPase system. An S. cerevisiae homo-
og, smp2, also affects nuclear mor-
hology. Of more obvious relevance to
nergy homeostasis, insulin causes mouse
ipin phosphorylation on serine and thre-
nine in a PI3-kinase- and mTOR-
ependent manner (Huffman et al.,
002). Without knowing lipin’s function,
t is hard to discern mechanistic conse-
uences of its phosphorylation, but it
ould be interesting to see if phos-
horylation affects the protein’s subcel-
ular distribution and if it has effects in
ssays based on the yeast functions.5
P R E V I E WMTable 1. Adiposity and insulin resistance: Not always a simple correlation
M
+ Adipose + Muscle M
Obese Lean Lipodystrophy fld lipin lipin
R
Adipose triacylglycerol up down down down up up
stores
Adipocyte number up down or no down ? ? ?
Schange
Insulin resistance up down up up down up
F




Note the difference from the usual correlation between adipose lipid content and insulin resistance and liver
Glipid content in lipodystrophy, the fld mouse, and the adipose lipin mouse but not in the muscle lipin mouse.
1Data are from Phan and Reue (2005), Reitman (2002), and references therein.
G
K
ETwo closely related genes, Lpin2 and t
Lpin3, are present in mice and humans p
(Peterfy et al., 2001). To date, no charac- t
terization has been reported for them. o
LPIN2 and LPIN3 show a broad tissue i
distribution in transcript databases, but w
it is not known if they complement Lpin1 d
function or if they are targets of insulin e
signaling. One possibility is that the ob-
served fld phenotype is determined by (
the tissues that lack all lipin-like proteins a
(loss of Lpin1 coupled with normal lack s
of Lpin2 and Lpin3 expression). s
Lipodystrophy and leanness are quite q
distinct conditions (Table 1). One way to o
conceptualize the difference is that, in li- p
podystrophy, there is a deficiency of adi- t
pose tissue (both cells and lipid cargo), o
wwhile, in leanness, the adipose tissue is
present, but its triacylglycerol content is n
reduced. In lipodystrophy, as a result of t
fthe missing adipocytes, there is increased
triacylglycerol deposition in nonadipose l
tissues, particularly liver. Such lipotoxi- l
city is a correlate of tissue insulin resis- a6I
ance. The contrasting physiology of li-
Hodystrophy and leanness may explain
l
he clinical observation that weight loss (
f 10 kg by liposuction does not improve
Hnsulin sensitivity, whereas this degree of
J
eight loss by diet and exercise pro- 1
uces significant metabolic benefit (Klein
Kt al., 2004). K
The Phan and Reue experiments (
Phan and Reue, 2005) showing obesity
P
s a consequence of lipin overexpres- N
ion complement the lipodystrophy re-
Pulting from lipin absence. Unanswered
1
uestions about lipin include the details
Pf its molecular function, how its overex-
Bression causes the observed pheno-
Rypes, why hepatic steatosis is present
4nly transiently in the fld mouse, and
hy the fld mouse develops peripheral S
Leuropathy. Presumably, this informa-
2ion will mesh with and complement in-
ormation derived from other models of S
Bipodystrophy and of obesity. Clearly, the
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